Transcriptional regulation of the p21((WAF1/CIP1)) gene

Experimental Cell Research

Volumn 246, Issue 2, 1999, Pages 280-289

  Gartel, Andrei L ^a   Tyner, Angela L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P21;

CELL CYCLE; GENE EXPRESSION; GENE TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EUKARYOTA;

EID: 0033080402     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4319     Document Type: Article

References (112)

1. Morgan D. O. Principles of CDK regulation. Nature. 374:1995;131-134.
2. Sherr C., Roberts J. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
3. Bates S., Bonetta L., Macallan D., Parry D., Holder A., Dickson C., Peters G. CDK6 and CDK4 are distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene. 9:1994;71-79.
4. Harper J. W., Adami G., Wei N., Keyomarsi K., Elledge S. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
5. Xiong Y., Hannon G., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
6. Harper J. W., Elledge S. J., Keyomarsi K., Dynlacht B., Tsai L., Zhang P., Dobtowolski S., Bai C., Connell-Crowley L., Swindell E., Fox M. P., Wei N. Inhibition of cyclin dependent kinases by p21. Mol. Biol. Cell. 6:1995;387-400.
7. El-Deiry W., Tokino T., Velculescu V., Levy D., Parsons R., Trent J., Lin D., Mercer W., Kinzler K., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
8. Noda A., Ning Y., Venable S. F., Pereira-Smith O. M., Smith J. R. Cloning of senescent cell derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:1994;90-98.
9. Jiang H., Lin J., Su Z., Collart F., Huberman E., Fisher P. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
10. Polyak K., Lee M., Erdjument-Bromage H., Koff A., Roberts J., Tempst P., Massague J. Cloning of p27, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78:1994;59-66.
11. Toyoshima H., Hunter T. p27, a novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21. Cell. 78:1994;67-74.
12. Lee M., Reynisdottir I., Massague J. Cloning of p57, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:1995;639-649.
13. Matsuoka S., Edwards M. C., Bai C., Parker S., Zhang P., Baldini A., Harper J. W., Elledge S. J. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:1995;650-662.
14. Serrano M., Hannon G., Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4. Nature. 366:1993;704-707.
15. Kamb A., Gruis N., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S., Stockert E., Day R. III, Johnson B., Skolnick M. A cell cycle regulator involved in genesis of many tumor types. Science. 264:1994;436-440.
16. ink4b. Nature. 371:1994;257-261.
17. Chan F. K., Zhang J., Cheng L., Shapiro D. N., Winoto A. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4. Mol. Cell Biol. 15:1995;2682-2688.
18. Hirai H., Roussel M. F., Kato J. Y., Ashmun R. A., Scherr C. J. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell Biol. 15:1995;2672-2681.
19. Serrano M., Lin A. W., McCurrach M. E., Beach D., Lowe S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:1997;593-602.
20. Serrano M. The tumor suppressor protein p16INK4a. Exp. Cell Res. 237:1997;7-13.
21. Deng C., Zhang P., Harper J. W., Elledge S. J., Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
22. Brugarolas J., Chadrasekaran C., Gordon J., Beach D., Jacks T., Hannon G. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature. 377:1995;552-557.
23. Dulic V., Stein G. H., Far D. F., Reed S. I. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell Biol. 18:1998;546-557.
24. Niculescu A. B. 3rd, Chen X., Smeets M., Hengst L., Prives C., Reed S. I. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell Biol. 18:1998;629-643.
25. Michieli P., Chedid D., Lin D., Pierce J., Mercer W., Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:1994;3391-3395.
26. Nourse J., Firpo E., Flanagan W. M., Coat S., Polyak K., Lee M. H., Massague J., Crabtree G. R., Roberts J. M. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature. 372:1994;570-573.
27. Mantel C., Luo Z., Canfield J., Braun S., Deng C., Broxmeyer H. E. Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo. Blood. 88:1996;3710-3719.
28. Halaban R., Cheng E., Zhang Y., Mandigo C. E., Miglarese M. R. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1. Oncogene. 16:1998;2489-2501.
29. Steinman R., Hoffman B., Iro A., Guillouf C., Liebermann D., El-Houseini M. Induction of p21(WAF1/CIP1) during differentiation. Oncogene. 9:1994;3389-3396.
30. Halevy O., Novitch B. G., Spicer D. B., Skapek S. X., Rhee J., Hannon G. J., Beach D., Lassar A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 267:1995;1018-1021.
31. Missero C., Calautti E., Eckner R., Chin J., Tsai L., Livingston D., Dotto G. P. Involvement of the cell-cycle inhibitor CIP1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA. 92:1995;5451-5455.
32. Huppi K., Siwarski D., Dosik J., Michieli P., Chedid M., Reed S., Mock B., Givol D., Mushinski J. F. Molecular cloning, sequencing, chromosomal location and expression of mouse p21 (Waf1). Oncogene. 9:1994;3017-3020.
33. Macleod K, . Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:1995;935-944.
34. Gartel A. L., Serfas M. S., Gartel M., Goufman E., Wu G. S., El-Deiry W. S., Tyner A. L. p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelial and during differentiation of the Caco-2 intestinal cell line. Exp. Cell Res. 227:1996;171-181.
35. Gartel A. L., Serfas M. S., Tyner A. L. p21-Negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213:1996;137-148.
36. Matsumura I., Ishikawa J., Nakajima K., Oritani K., Tomiyama Y., Miyagawa J., Kato T., Miyazaki H., Matsuzawa Y., Kanakura Y. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/CIP1) by STAT5. Mol. Cell Biol. 17:1997;2933-2943.
37. 3. Genes Dev. 10:1996;142-153.
38. Di Cunto F., Topley G., Calautti E., Hsiao J., Ong L., Seth P. K., Dotto G. P. Inhibitory function of p21CIP1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science. 280:1998;1069-1072.
39. Brown J. P., Wei W., Sedivy J. M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science. 277:1997;831-834.
40. Polyak K., Waldman T., He T. C., Kinzler K. W., Vogelstein B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10:1996;1945-1952.
41. Gorospe M., Cirielli C., Wang X., Seth P., Capogrossi M., Holbrook N. p21 (WAF1/CIP1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 14:1997;929-935.
42. Boudreau N., Werb Z., Bissell M. J. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc. Natl. Acad. Sci. USA. 93:1996;3509-3513.
43. Duttaroy A., Qian J. F., Smith J. S., Wang E. Up-regulated p21(CIP1) expression is part of the regulation quantitatively controlling serum deprivation-induced apoptosis. J. Cell Biochem. 64:1997;434-446.
44. WAF1/CIP1. Progress in Molecular and Subcellular Biology, Inhibitors of Cell Growth. 1998;Springer-Verlag, Heidelberg. p. 43-71.
45. Kelman Z. PCNA: Structure, functions and interactions. Oncogene. 14:1997;629-640.
46. Zhang H., Xiong Y., Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell. 4:1993;897-906.
47. Zhang H., Hannon G., Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1994;1750-1758.
48. LaBaer J., Garrett M. D., Stevenson L. F., Slingerland J. M., Sandhu C., Chou H. S., Fattaey A., Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:1997;847-862.
49. Gorospe M., Wang X., Holbrook N. J. p53-dependent elevation of p21Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system. Mol. Cell Biol. 18:1998;1400-1407.
50. Timchenko N. A., Wilde M., Nakanishi M., Smith J. R., Darlington G. J. CCAAT/enhancer-binding protein α (C/EBPα) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 10:1996;804-815.
51. Timchenko N. A., Harris T. E., Wilde M., Bilyeu T. A., Burgess-Beusse B. L., Finegold M. J., Darlington G. J. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol. Cell. Biol. 17:1997;7353-7361.
52. Butz K., Geisen C., Ullmann A., Zentgraf H., Hoppe-Seyler F. Uncoupling of p21WAF1/CIP1/SDI1 mRNA and protein expression upon genotoxic stress. Oncogene. 17:1998;781-787.
53. Wiman K. G. p53: Emergency brake and target for cancer therapy. Exp. Cell Res. 237:1997;14-18.
54. El-Deiry W. S., Tokino T., Waldman T., Oliner J D., Velculscu V. E., Burrel M., Hill D E., Healy E., Rees J. L., Hamilton S. R., Kinzler K. W., Vogelstein B. Topological control of p21 (WAF1/CIP1) expression in normal and neoplastic tissues. Cancer Res. 55:1995;2910-2919.
55. Dulic V., Kaufman W. K., Wilson S. J., Tlsty T. D., Lees E., Harper J. W., Elledge S. J., Reed S. I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76:1994;1013-1023.
56. Namba H., Hara T., Tukazaki T., Migita K., Ishikawa N., Ito K., Nagataki S., Yamashita S. Radiation-induced G1 arrest is selectively mediated by the p53-WAF1/Cip1 pathway in human thyroid cells. Cancer Res. 55:1995;2075-2080.
57. Waldman T., Kinzler K. W., Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55:1995;5187-5190.
58. McDonald E. 3rd, Wu G. S., Waldman T., El-Deiry W. S. Repair defect in p21 WAF1/CIP1 -/- human cancer cells. Cancer Res. 56:1996;2250-2255.
59. Lanni J. S., Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell Biol. 18:1998;1055-1064.
60. Cayrol C., Flemington E. K. The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15:1996;2748-2759.
61. Bacus S. S., Yarden Y., Oren M. Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells. Oncogene. 12:1996;2535-2547.
62. Linke S. P., Clarkin K. C., Di Leonardo A., Tsou A., Wahl G. M. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:1996;934-947.
63. Bash J., Zong W. X., Gelinas C. c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition. Mol. Cell Biol. 17:1997;6526-6536.
64. Lloyd A. C., Obermuller F., Staddon S., Barth C. F., McMahon M., Land H. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev. 11:1997;663-677.
65. Missero C., Di Cunto F., Kiyokawa H., Koff A., Dotto G. P. The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10:1996;3065-3075.
66. Khosravi-Far R., Solski P. A., Clark G. J., Kinch M. S., Der C. J. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol. Cell Biol. 15:1995;6443-6453.
67. Qiu R. G., Chen J., McCormick F., Symons M. A role for Rho in Ras transformation. Proc. Natl. Acad. Sci. USA. 92:1995;11781-11785.
68. Olson M. F., Paterson H. F., Marshall C. J. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature. 394:1998;295-299.
69. Sewing A., Wiseman B., Lloyd A. C., Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol. Cell Biol. 17:1997;5588-5597.
70. Woods D., Parry D., Cherwinski H., Bosch E., Lees E., McMahon M. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell Biol. 17:1997;5598-5611.
71. Decker S. J. Nerve growth factor induced growth arrest and induction of p21 CIP1/WAF1 in NIH-3T3 cells expressing TrkA. J. Biol. Chem. 270:1995;30841-30844.
72. Pumiglia K. M., Decker S. J. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA. 94:1997;448-452.
73. Kennett S. B., Udvadia A. J., Horowitz J. M. Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25:1997;3110-3117.
74. Biggs J. R., Kudlow J. E., Kraft A. S. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271:1996;901-906.
75. Somasundaram K., Zhang H., Zeng Y. X., Houvras Y., Peng Y., Zhang H., Wu G. S., Licht J. D., Weber B. L., El-Deiry W. S. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature. 389:1997;187-190.
76. Datto M. B., Yu Y., Wang X.-F. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:1995;28623-28628.
77. Prowse, D. M. Bolgan, L. Molnar, A. Dotto, G. P. 1997, Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation, J. Biol. Chem. 272, 1308, 1314, 1997.
78. Nakano K., Mizuno T., Sowa Y., Orita T., Yoshino T., Okuyama Y., Fujita T., Ohtani-Fujita N., Matsukawa Y., Tokino T., Yamagishi H., Oka T., Nomura H., Sakai T. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 272:1997;22199-22206.
79. Sowa Y., Orita T., Minamikawa S., Nakano K., Mizuno T., Nomura H., Sakai T. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 241:1997;142-150.
80. Lee S.-J., Ha M. J., Lee J., Nguyen P. M., Choi Y. H., Pirnia F., Kang W.-K., Wang X.-F., Kim S.-J., Trepel J. B. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21 (WAF1/CIP1) in human prostate carcinoma cells. J. Biol. Chem. 273:1998;10618-10623.
81. Li J.-M., Datto M., Shen X., Hu P., Yu Y., Wang X.-F. Sp1, but not Sp3 functions to mediate promoter activation by TGF-β through canonical Sp1 binding sites. Nucleic Acids Res. 26:1998;2449-2456.
82. Moustakas A., Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA. 95:1998;6733-6738.
83. Giles R. H., Peters D. J., Breuning M. H. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 14:1998;178-183.
84. Yan G. Z., Ziff E. B. Nerve growth factor induces transcription of the p21 WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating the Sp1 transcription factor. J. Neurosci. 17:1997;6122-6132.
85. Billon N., van Grunsven L. A., Rudkin B. B. The CDK inhibitor p21WAF1/Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene. 13:1996;2047-2054.
86. Puri P. L., Avantaggiati M. L., Balsano C., Sang N., Graessmann A., Giordano A., Levrero M. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16:1997;369-383.
87. Mutoh H., Naya F. J., Tsai M. J., Leiter A. B. The basic helix-loop-helix protein BETA2 interacts with p300 to coordinate differentiation of secretin-expressing enteroendocrine cells. Genes Dev. 12:1998;820-830.
88. Prabhu S., Ignatova A., Park S. T., Sun X. H. Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins. Mol. Cell Biol. 17:1997;5888-5896.
89. Owen G. I., Richer J. K., Tung L., Takimoto G., Horwitz K. B. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem. 273:1998;10696-10701.
90. Zhang H., Somasundaram K., Peng Y., Tian H., Zhang H., Bi D., Weber B. L., El-Deiry W. S. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene. 16:1998;1713-1721.
91. Garkavtsev I., Grigorian I. A., Ossovskaya V. S., Chernov M. V., Chumakov P. M., Gudkov A. V. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature. 391:1998;295-298.
92. Avantaggiati M. L., Ogryzko V., Gardner K., Giordano A., Levine A S., Kelly K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell. 89:1997;1175-1184.
93. Lill N. L., Grossman S. R., Ginsberg D., DeCaprio J., Livingston D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature. 387:1997;823-827.
94. Gu W., Shi X. L., Roeder R. G. Synergistic activation of transcription by CBP and p53. Nature. 387:1997;819-823.
95. Tanaka N., Ishihara M., Lamphier M. S., Nozawa H., Matsuyama T., Mak T. W., Aizawa S., Tokino T., Oren M., Taniguchi T. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature. 382:1996;816-818.
96. Zeng Y. X., Somasundaram K., el-Deiry W. S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat. Genet. 15:1997;78-82.
97. WAF1/CIP1. Oncogene. 1999.
98. Hiyama H., Iavarone A., Reeves S. A. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene. 16:1998;1513-1523.
99. Trotter M. J., Tang L., Tron V. A. Overexpression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in human cutaneous malignant melanoma. J. Cutan. Pathol. 24:1997;265-271.
100. Ihle J. N. STATs and MAPKs: obligate or opportunistic partners in signaling. BioEssays. 18:1996;95-98.
101. Chin Y. E., Kitagawa M., Su W.-C. S., You Z.-H., Iwamoto Y., Fu X.-Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science. 272:1996;719-722.
102. Sangfelt O., Erickson S., Einhorn S., Grander D. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines. Oncogene. 14:1997;415-423.
103. Hobeika A. C., Subramaniam P. S., Johnson H. M. IFNα induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells. Oncogene. 14:1997;1165-1170.
104. Su W. C., Kitagawa M., Xue N., Xie B., Garofalo S., Cho J., Deng C., Horton W A., Fu X. Y. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature. 386:1997;288-292.
105. Bellido T., O'Brien C. A., Roberson P. K., Manolagas S. C. Transcriptional activation of the p21(WAF1/CIP1/SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro- differentiating and anti-apoptotic effects on human osteoblastic cells. J. Biol. Chem. 273:1998;21137-21144.
106. Cram E. J., Ramos R. A., Wang E. C., Cha H. H., Nishio Y., Firestone G. L. Role of the CCAAT/enhancer binding protein-alpha transcription factor in the glucocorticoid stimulation of p21Waf1/Cip1 gene promoter activity in growth-arrested rat hepatoma cells. J. Biol. Chem. 273:1998;2008-2014.
107. Chinery R., Brockman J., Peeler M. O., Shyr Y., Beauchamp R. D., Coffey R. J. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21 (WAF1/CIP1) via C/EBPβ Nature Med. 3:1997;1233-1241.
108. Smith R. C., Branellec D., Gorski D. H., Guo K., Perlman H., Dedieu J. F., Pastore C., Mahfoudi A., Denefle P., Isner J. M., Walsh K. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 11:1997;1674-1689.
109. Liu M., Iavarone A., Freedman L. P. Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J. Biol. Chem. 271:1996;31723-31728.
110. Tong B., Grimes H. L., Yang T. Y., Bear S. E., Qin Z., Du K., El-Deiry W. S., Tsichlis P. N. The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol. Cell Biol. 18:1998;2462-2473.
111. Ray R. B., Steele R., Meyer K., Ray R. Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity. Gene. 208:1998;331-336.
112. Coqueret, O. Berube, G. Nepveu, A. 1998, The mammalian Cut homeodomain protein functions as a cell-cycle-dependent transcriptional repressor which down modulates p21(WAF1/CIP1/SDI1) in S phase, EMBO J. 17, 4680, 4694, 1998.